Browse EV MemProt Atlas
Frequency:
literature support frequency.
EVMP score:

annotation confidence score.

Extremely high >= 0.85High >= 0.70Medium >= 0.55Low >= 0.40
UniProt IDProtein namesProtein classificationTransmembrane countRelated DiseasesMediation categoriesDownload
GLRA1P23415Glycine receptor subunit alpha-1 (Glycine receptor 48 kDa subunit) (Glycine receptor strychnine-binding subunit)4SepsisTonus and reflex abnormalityClinical-translation mediationFusion and delivery mediationReceptor-signaling mediation20.50
GLT10Q86SR1Polypeptide N-acetylgalactosaminyltransferase 10 (EC 2.4.1.41) (Polypeptide GalNAc transferase 10) (GalNAc-T10) (pp-GaNTase 10) (Protein-UDP acetylgalactosaminyltransferase 10) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 10)EnzymesMetabolic proteinsPredicted intracellular proteins1Metabolism mediation20.50
GLT12Q8IXK2Polypeptide N-acetylgalactosaminyltransferase 12 (EC 2.4.1.41) (Polypeptide GalNAc transferase 12) (GalNAc-T12) (pp-GaNTase 12) (Protein-UDP acetylgalactosaminyltransferase 12) (UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 12)Disease related genesEnzymesHuman disease related genesMetabolic proteinsPotential drug targetsPredicted intracellular proteins1Clinical-translation mediationMetabolism mediation20.50
GRD2IA4D2P6Delphilin (Glutamate receptor, ionotropic, delta 2-interacting protein 1)Metabolism mediationReceptor-signaling mediation20.50
GRIK5Q16478Glutamate receptor ionotropic, kainate 5 (GluK5) (Excitatory amino acid receptor 2) (EAA2) (Glutamate receptor KA-2) (KA2)3Fusion and delivery mediationReceptor-signaling mediation20.50
GTR1P11166Solute carrier family 2, facilitated glucose transporter member 1 (Glucose transporter type 1, erythrocyte/brain) (GLUT-1) (HepG2 glucose transporter)Cancer-related genesDisease related genesHuman disease related genesMetabolic proteinsPlasma proteinsPotential drug targetsPredicted intracellular proteinsPredicted membrane proteinsTransporters12Skin diseaseClinical-translation mediationFusion and delivery mediationMetabolism mediation20.50
GTR12Q8TD20Solute carrier family 2, facilitated glucose transporter member 12 (Glucose transporter type 12) (GLUT-12)Metabolic proteinsPredicted membrane proteinsTransporters12Fusion and delivery mediation20.50
GTR14Q8TDB8Solute carrier family 2, facilitated glucose transporter member 14 (Glucose transporter type 14) (GLUT-14)Metabolic proteinsPredicted intracellular proteinsPredicted membrane proteinsTransporters12Fusion and delivery mediation20.50
GUC1AP43080Guanylyl cyclase-activating protein 1 (GCAP 1) (Guanylate cyclase activator 1A)Disease related genesHuman disease related genesPredicted intracellular proteinsReceptor-signaling mediation20.50
HLAAP04439HLA class I histocompatibility antigen, A alpha chain (Human leukocyte antigen A) (HLA-A)1Acute myeloid leukaemiaAdhesion and uptake mediationClinical-translation mediationFusion and delivery mediationImmune mediationMetabolism mediation20.50
IFM1P13164Interferon-induced transmembrane protein 1 (Dispanin subfamily A member 2a) (DSPA2a) (Interferon-induced protein 17) (Interferon-inducible protein 9-27) (Leu-13 antigen) (CD antigen CD225)CD markersPlasma proteinsPredicted membrane proteinsTransporters1Fusion and delivery mediationImmune mediation20.50
ILRL1Q01638Interleukin-1 receptor-like 1 (EC 3.2.2.6) (Protein ST2)Candidate cardiovascular disease genesEnzymesPlasma proteinsPredicted intracellular proteinsPredicted membrane proteinsPredicted secreted proteins1AsthmaChronic obstructive pulmonary diseaseAdhesion and uptake mediationClinical-translation mediationFusion and delivery mediationImmune mediationReceptor-signaling mediation20.50
ITA8P53708Integrin alpha-8 [Cleaved into: Integrin alpha-8 heavy chain; Integrin alpha-8 light chain]Disease related genesHuman disease related genesPlasma proteinsPredicted membrane proteins1Adhesion and uptake mediationFusion and delivery mediationReceptor-signaling mediation20.50
ITAXP20702Integrin alpha-X (CD11 antigen-like family member C) (Leu M5) (Leukocyte adhesion glycoprotein p150,95 alpha chain) (Leukocyte adhesion receptor p150,95) (CD antigen CD11c)CD markersFDA approved drug targetsPredicted intracellular proteinsPredicted membrane proteins1Adhesion and uptake mediationClinical-translation mediationFusion and delivery mediationImmune mediationReceptor-signaling mediation20.50
ITPI2P28290Protein ITPRID2 (Cleavage signal-1 protein) (CS-1) (ITPR-interacting domain-containing protein 2) (Ki-ras-induced actin-interacting protein) (Sperm-specific antigen 2)Plasma proteinsPredicted intracellular proteinsOther mediation20.50
KC1DP48730Casein kinase I isoform delta (CKI-delta) (CKId) (EC 2.7.11.1) (Tau-protein kinase CSNK1D) (EC 2.7.11.26)Disease related genesEnzymesHuman disease related genesPlasma proteinsPotential drug targetsPredicted intracellular proteinsMature B-cell leukaemiaPancreatic cancerClinical-translation mediationFusion and delivery mediationMetabolism mediationReceptor-signaling mediation20.50
KCNH8Q96L42Voltage-gated delayed rectifier potassium channel KCNH8 (ELK1) (hElk-1) (Ether-a-go-go-like potassium channel 3) (ELK channel 3) (ELK3) (Potassium voltage-gated channel subfamily H member 8) (Voltage-gated potassium channel subunit Kv12.1)Predicted membrane proteinsVoltage-gated ion channels6Clinical-translation mediationFusion and delivery mediation20.50
KCNKHQ96T54Potassium channel subfamily K member 17 (2P domain potassium channel Talk-2) (Acid-sensitive potassium channel protein TASK-4) (TWIK-related acid-sensitive K(+) channel 4) (TWIK-related alkaline pH-activated K(+) channel 2) (TALK-2)Predicted membrane proteinsTransportersVoltage-gated ion channels4Fusion and delivery mediation20.50
KCNU1A8MYU2Potassium channel subfamily U member 1 (Calcium-activated potassium channel subunit alpha-3) (Calcium-activated potassium channel, subfamily M subunit alpha-3) (KCa5) (Slowpoke homolog 3)7Fusion and delivery mediation20.50
KISSRQ969F8KiSS-1 receptor (KiSS-1R) (G-protein coupled receptor 54) (G-protein coupled receptor OT7T175) (hOT7T175) (Hypogonadotropin-1) (Kisspeptins receptor) (Metastin receptor)Disease related genesG-protein coupled receptorsHuman disease related genesPotential drug targetsPredicted membrane proteinsTransporters7Allergic/hypersensitivity disorderProstate cancerClinical-translation mediationReceptor-signaling mediation20.50
L1CAMP32004Neural cell adhesion molecule L1 (N-CAM-L1) (NCAM-L1) (CD antigen CD171)CD markersDisease related genesHuman disease related genesPlasma proteinsPredicted intracellular proteinsPredicted membrane proteins1Adrenal cancerBrain cancerAdhesion and uptake mediationClinical-translation mediationImmune mediation20.50
LAMP2P13473Lysosome-associated membrane glycoprotein 2 (LAMP-2) (Lysosome-associated membrane protein 2) (CD107 antigen-like family member B) (LGP-96) (CD antigen CD107b)CD markersDisease related genesHuman disease related genesPlasma proteinsPotential drug targetsPredicted membrane proteinsTransporters1Inborn carbohydrate metabolism errorClinical-translation mediationFusion and delivery mediationImmune mediation20.50
LIGO1Q96FE5Leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 1 (Leucine-rich repeat and immunoglobulin domain-containing protein 1) (Leucine-rich repeat neuronal protein 1) (Leucine-rich repeat neuronal protein 6A)Disease related genesHuman disease related genesPotential drug targetsPredicted intracellular proteinsPredicted membrane proteinsTransporters1Multiple sclerosisClinical-translation mediationReceptor-signaling mediation20.50
LIRA6Q6PI73Leukocyte immunoglobulin-like receptor subfamily A member 6 (Immunoglobulin-like transcript 8) (ILT-8) (Leukocyte Ig-like receptor)1Immune mediation20.50
LPAR3Q9UBY5Lysophosphatidic acid receptor 3 (LPA receptor 3) (LPA-3) (Lysophosphatidic acid receptor Edg-7)7FibrosisSystemic sclerosisClinical-translation mediationReceptor-signaling mediation20.50

501-525 of 2,176 proteins

Page